283 related articles for article (PubMed ID: 19073395)
61. Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulations.
Kardos P; Beeh KM; Sent U; Mueck T; Gräter H; Michel MC
BMC Pharmacol Toxicol; 2018 Jul; 19(1):40. PubMed ID: 29973292
[TBL] [Abstract][Full Text] [Related]
62. [Effect of lasolvan on the rheologic properties of sputum].
Chuchalin AG; Solopov VN; Kolganova NA; Plisko LF
Klin Med (Mosk); 1987 Mar; 65(3):52-4. PubMed ID: 3298838
[No Abstract] [Full Text] [Related]
63. Safety of ambroxol in the treatment of airway diseases in adult patients.
Cazan D; Klimek L; Sperl A; Plomer M; Kölsch S
Expert Opin Drug Saf; 2018 Dec; 17(12):1211-1224. PubMed ID: 30372367
[TBL] [Abstract][Full Text] [Related]
64. [Ambroxol in bronchopulmonary pathology in children].
Berni M; Collina A; Zavattini G
Clin Ter; 1983 Sep; 106(5):351-5. PubMed ID: 6641103
[No Abstract] [Full Text] [Related]
65. Plastic bronchitis as an unusual cause of mucus plugging in cystic fibrosis.
Mateos-Corral D; Cutz E; Solomon M; Ratjen F
Pediatr Pulmonol; 2009 Sep; 44(9):939-40. PubMed ID: 19658112
[TBL] [Abstract][Full Text] [Related]
66. Clinical study on Lasolvan in chronic obstructive pulmonary disease.
Král B; Ellás J; Rozánek P; Jirkal J; Tilser P
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1981; 24(5):601-6. PubMed ID: 7051260
[No Abstract] [Full Text] [Related]
67. Pharmacological properties of the extract and some isolated compounds of Clausena lansium stem bark: anti-trichomonal, antidiabetic, anti-inflammatory, hepatoprotective and antioxidant effects.
Adebajo AC; Iwalewa EO; Obuotor EM; Ibikunle GF; Omisore NO; Adewunmi CO; Obaparusi OO; Klaes M; Adetogun GE; Schmidt TJ; Verspohl EJ
J Ethnopharmacol; 2009 Feb; 122(1):10-9. PubMed ID: 19095054
[TBL] [Abstract][Full Text] [Related]
68. [Therapeutic information. Trial of FF 65 syrup for children].
Jougleux M
Probl Actuels Otorhinolaryngol; 1967; ():323-8. PubMed ID: 6053853
[No Abstract] [Full Text] [Related]
69. Effects and mechanisms of ambroxol inhalation (Mucosolvan
Yang Z; Xiao X; Huang Y; He X; Lu Q; Chen S; Lin Z
Pharmazie; 2017 Oct; 72(10):604-607. PubMed ID: 29441886
[TBL] [Abstract][Full Text] [Related]
70. [The cleaning system of the airways: physiology, pathophysiology and effects of ambroxol].
Wunderer H; Morgenroth K; Weis G
Med Monatsschr Pharm; 2009 Feb; 32(2):42-7. PubMed ID: 19263911
[TBL] [Abstract][Full Text] [Related]
71. [Pharmacologic therapy in pharyngitis].
Palćhun VT; Poliakova TS; Beliakova LV; Kriukov AI
Vestn Otorinolaringol; 1994; (4):36-41. PubMed ID: 7871664
[TBL] [Abstract][Full Text] [Related]
72. Flurbiprofen: new indication. Lozenges: NSAIDs are not to be taken like sweets!
Prescrire Int; 2007 Feb; 16(87):13. PubMed ID: 17323518
[TBL] [Abstract][Full Text] [Related]
73. [Severe acute bronchitis].
Gillissen A
MMW Fortschr Med; 2009 Aug; 151(34-35):49-50. PubMed ID: 19771793
[No Abstract] [Full Text] [Related]
74. Carbocisteine can scavenge reactive oxygen species in vitro.
Nogawa H; Ishibashi Y; Ogawa A; Masuda K; Tsubuki T; Kameda T; Matsuzawa S
Respirology; 2009 Jan; 14(1):53-9. PubMed ID: 19144049
[TBL] [Abstract][Full Text] [Related]
75. [Pharmacy based sore throat therapy according to current guidelines].
Klimek L; Sperl A
Med Monatsschr Pharm; 2015 Dec; 38(12):503-8. PubMed ID: 26837157
[TBL] [Abstract][Full Text] [Related]
76. Pharmacological characterization of 3-[3-tert-butylsulfanyl-1-[4-(6-methoxy-pyridin-3-yl)-benzyl]-5-(pyridin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid (AM103), a novel selective 5-lipoxygenase-activating protein inhibitor that reduces acute and chronic inflammation.
Lorrain DS; Bain G; Correa LD; Chapman C; Broadhead AR; Santini AM; Prodanovich P; Darlington JV; Hutchinson JH; King C; Lee C; Baccei C; Li Y; Arruda JM; Evans JF
J Pharmacol Exp Ther; 2009 Dec; 331(3):1042-50. PubMed ID: 19749079
[TBL] [Abstract][Full Text] [Related]
77. Acute sore throat revisited: clinical and experimental evidence for the efficacy of over-the-counter AMC/DCBA throat lozenges.
Oxford JS; Leuwer M
Int J Clin Pract; 2011 May; 65(5):524-30. PubMed ID: 21489076
[No Abstract] [Full Text] [Related]
78. [Acute bronchitis: really not a case for antibiotics?] [Interview by Barbara Kreutzkamp].
Gillissen A
MMW Fortschr Med; 2005 Feb; 147(8):13. PubMed ID: 18441557
[No Abstract] [Full Text] [Related]
79. [Associations of antibiotics with non-steroid anti-inflammatory agents. Clinical observations on the treatment of acute and chronic bronchitis with tetracycline-oxolamine].
Cairella M
Policlinico Prat; 1970 Sep; 77(37):1183-6. PubMed ID: 5458803
[No Abstract] [Full Text] [Related]
80. A novel anti-inflammatory treatment for bradykinin-induced sore throat or pharyngitis.
Leyva-Grado V; Pugach P; Sadeghi-Latefi N
Immun Inflamm Dis; 2021 Dec; 9(4):1321-1335. PubMed ID: 34153179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
